News
-
-
-
PRESS RELEASE
EQS-Adhoc: Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
Marinomed Biotech AG announces cash capital increase of EUR 2 million to cover short-term capital needs. Existing shareholders will have subscription rights. Goal is to generate at least EUR 2 million in gross proceeds -
-
-
-
-
-
-
PRESS RELEASE
Knorr-Bremse proposes higher dividend – € 1.90 per share planned
Knorr-Bremse AG proposes a higher dividend of €1.90 per share for the 2025 fiscal year and announces new elections to the Supervisory Board, with Dr. Christian Schlögel nominated to succeed Dr. Sigrid Nikutta. 2025 Annual Report is published
